Geosearch / Live Stats / Bug Report / FAQ / About LinkedCT

Eligibility: 2de298b14d202adf1aa39f706f99f889 [RDF]

Label 2de298b14d202adf1aa39f706f99f889
Slug 2de298b14d202adf1aa39f706f99f889
Criteria DISEASE CHARACTERISTICS: Histologically proven myelodysplastic syndrome Less than 30% blasts in bone marrow PATIENT CHARACTERISTICS: Age: 18 and over Performance Status: Zubrod 0-2 Karnofsky 60-100% ECOG 0-2 Hematopoietic: Not specified Hepatic: Bilirubin no greater than 2 mg/dL Renal: Creatinine no greater than 2 mg/dL Cardiovascular: No New York Heart Association Class IV disease No antihypertensive medication within 24 hours of amifostine administration Other: Not pregnant or nursing Effective contraceptive method must be used during study No medical illness No psychosis Eligible patients with an HLA compatible donor are referred to bone marrow transplantation PRIOR CONCURRENT THERAPY: Biologic therapy: Not specified Chemotherapy: No prior chemotherapy within 4 weeks of study and recovered Endocrine therapy: Not specified Radiotherapy: Not specified Surgery: Not specified
Maximum age N/A
Healthy volunteers No
Study pop
Minimum age 18 Years
Gender Both
Sampling method
Provenances http://clinicaltrials.gov/show/NCT00003048?displayxml=true
Similars None
Interlinks None